Recently, the pharmacotherapy of MASLD mainly focuses on three parts of mechanisms: anti-inflammatory (ASK1 inhibitors), anti-diabetic (GCGR agonists, PPAR agonists), and prevention of lipotoxicity (FXR agonists, FGF21 analogues) (Wei et al., 2024)
Decreasing Appetite: GLP-1 agonists suppress appetite signals in the brain, making it easier to resist cravings and stick to a healthy eating plan
Essentially, the drug would become a bridge to a healthier lifestyle
Based on publicly available information, here's how Elevate Health's offerings generally position within the competitive landscape
However, long-term risks such as rare adverse effects, metabolic effects over years, effects on bone, gallbladder, and pancreas need phase-3 trials and post-marketing surveillance to ensure the medication is safe for long-term use